Global Bioenergies SA
F:1DK
Intrinsic Value
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. [ Read More ]
The intrinsic value of one 1DK stock under the Base Case scenario is 0.484 EUR. Compared to the current market price of 1.866 EUR, Global Bioenergies SA is Overvalued by 74%.
Valuation Backtest
Global Bioenergies SA
Run backtest to discover the historical profit from buying and selling 1DK stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Global Bioenergies SA
Current Assets | 15m |
Cash & Short-Term Investments | 11.8m |
Receivables | 2.2m |
Other Current Assets | 947k |
Non-Current Assets | 3.2m |
Long-Term Investments | 341k |
PP&E | 2.5m |
Intangibles | 327k |
Current Liabilities | 15.4m |
Accounts Payable | 2.4m |
Accrued Liabilities | 559k |
Other Current Liabilities | 12.5m |
Non-Current Liabilities | 56k |
Other Non-Current Liabilities | 56k |
Earnings Waterfall
Global Bioenergies SA
Revenue
|
3.2m
EUR
|
Cost of Revenue
|
1.5m
EUR
|
Gross Profit
|
4.8m
EUR
|
Operating Expenses
|
-14.5m
EUR
|
Operating Income
|
-9.7m
EUR
|
Other Expenses
|
1.1m
EUR
|
Net Income
|
-8.7m
EUR
|
Free Cash Flow Analysis
Global Bioenergies SA
1DK Profitability Score
Profitability Due Diligence
Global Bioenergies SA's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
Score
Global Bioenergies SA's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
1DK Solvency Score
Solvency Due Diligence
Global Bioenergies SA's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Global Bioenergies SA's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
1DK Price Targets Summary
Global Bioenergies SA
According to Wall Street analysts, the average 1-year price target for 1DK is 3.771 EUR with a low forecast of 3.638 EUR and a high forecast of 3.981 EUR.
Shareholder Return
ALGBE Price
Global Bioenergies SA
Average Annual Return | -2.67% |
Standard Deviation of Annual Returns | 57.73% |
Max Drawdown | -81% |
Market Capitalization | 32.5m EUR |
Shares Outstanding | 18 091 600 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company is headquartered in Evry, Ile-De-France. The company went IPO on 2011-06-09. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. The company distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. The company operates through Syngip.
Contact
IPO
Employees
Officers
The intrinsic value of one 1DK stock under the Base Case scenario is 0.484 EUR.
Compared to the current market price of 1.866 EUR, Global Bioenergies SA is Overvalued by 74%.